Vital Access: Singapore's medtech startup Advent Access acquires vascular tech company in US

Advent will establish a portfolio of vascular access solutions with the potential to address the key gaps in enabling haemodialysis to be delivered in alternative care environments Singapore-based medtech startup Advent Access, which focuses on end-stage renal disease management, announced today certain key assets of Vital Access, a vascular technology company headquartered in the US. The [...]The post Singapore's medtech startup Advent Access acquires vascular tech company in US appeared first on e27.